NSF Reverses Policy Limiting Grant Proposal Submissions

Scientists will no longer be limited to one proposal as the lead or co-lead investigator per year.

Written byAshley P. Taylor
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

ABOVE: NATIONAL SCIENCE FOUNDATION

The National Science Foundation’s biology branch has rescinded a policy that limited the number of grant proposals on which scientists could be listed as principal investigator to one per year, the agency announced last Thursday (November 15). The change was effective immediately.

In August 2018, the biology directorate of the National Science Foundation (NSF) proclaimed that in order to deal with the flood of grant proposals it was receiving, the office would only allow each scientist to submit one proposal as the principal investigator (PI) or co-PI. The rule would apply to the directorate’s three core tracks and not to other NSF programs. Its intention was to prevent scientists from resubmitting previously rejected grant proposals with only minor changes, Science reported in September.

Then came the backlash. In September, 70 biologists signed a letter to NSF director France Córdova requesting that the policy be reversed, and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies